HY-152534-100mg
|
MedChemexpress LLC
|
MenA-IN-2
|
|
COVID-19-immunoregulation
|
|
HY-152534-25mg
|
MedChemexpress LLC
|
MenA-IN-2
|
|
COVID-19-immunoregulation
|
|
HY-152534-5mg
|
MedChemexpress LLC
|
MenA-IN-2
|
|
COVID-19-immunoregulation
|
|
HY-152534-50mg
|
MedChemexpress LLC
|
MenA-IN-2
|
|
COVID-19-immunoregulation
|
|
HY-W039897-1g
|
MedChemexpress LLC
|
Methyl Alpha-D-mannopyranoside [CAS 617-04-9]
|
|
COVID-19-immunoregulation
|
|
HY-W039897-500mg
|
MedChemexpress LLC
|
Methyl Alpha-D-mannopyranoside [CAS 617-04-9]
|
|
COVID-19-immunoregulation
|
|
HY-W039897-1mL
|
MedChemexpress LLC
|
Methyl Alpha-D-mannopyranoside [CAS 617-04-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-153009-10mg
|
MedChemexpress LLC
|
MMV676584 [CAS 750621-19-3]
|
|
COVID-19-immunoregulation
|
|
HY-153009-25mg
|
MedChemexpress LLC
|
MMV676584 [CAS 750621-19-3]
|
|
COVID-19-immunoregulation
|
|
HY-153009-5mg
|
MedChemexpress LLC
|
MMV676584 [CAS 750621-19-3]
|
|
COVID-19-immunoregulation
|
|
HY-153009-50mg
|
MedChemexpress LLC
|
MMV676584 [CAS 750621-19-3]
|
|
COVID-19-immunoregulation
|
|
HY-148478-10mg
|
MedChemexpress LLC
|
MMV688845 [CAS 2208962-35-8]
|
|
|
|
HY-148478-100mg
|
MedChemexpress LLC
|
MMV688845 [CAS 2208962-35-8]
|
|
|
|
HY-148478-25mg
|
MedChemexpress LLC
|
MMV688845 [CAS 2208962-35-8]
|
|
|
|
HY-148478-5mg
|
MedChemexpress LLC
|
MMV688845 [CAS 2208962-35-8]
|
|
|
|
HY-148478-50mg
|
MedChemexpress LLC
|
MMV688845 [CAS 2208962-35-8]
|
|
|
|
HY-148478-1mL
|
MedChemexpress LLC
|
MMV688845 [CAS 2208962-35-8] (10mM in DMSO)
|
|
|
|